TCL Archive Also NCI Cancels von Eschenbach’s Farewell Party, Returns Gift Contributions Amid Ethics Questions. May 19, 2006
TCL Archive In Brief: Reauthorization May Be Wrapped Up This Week As House, Senate Work Toward Compromise October 14, 1988
TCL Archive ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards? November 8, 2002
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive In Brief: O’Conor Names NCI Liaison To IARC, Saunders Acting IA Director Susan Sieber DCCP Deputy May 27, 1983
